INOTIV INC. - COMMON STOCK

Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions

21 Sep 2021 09:00:02 By Nasdaq GlobeNewswire

Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

31 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results

11 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories

02 Aug 2021 12:15:00 By Nasdaq GlobeNewswire

Inotiv, Inc. to Report Third Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, August 11, 2021

22 Jul 2021 16:05:01 By Nasdaq GlobeNewswire

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

15 Jul 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio

12 Jul 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort

28 Jun 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv Set to Join Russell 3000® Index and Russell 2000® Index

07 Jun 2021 16:15:00 By Nasdaq GlobeNewswire

Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity

27 May 2021 08:33:00 By Nasdaq GlobeNewswire

Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings

11 May 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results

05 May 2021 16:05:01 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.

30 Apr 2021 15:40:00 By Nasdaq GlobeNewswire

Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021

26 Apr 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

23 Apr 2021 11:15:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares

21 Apr 2021 06:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Proposed Public Offering of Common Shares

20 Apr 2021 17:16:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021

20 Apr 2021 17:12:42 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations

19 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

16 Apr 2021 08:33:00 By Nasdaq GlobeNewswire